TrueNorth Capital
@truenorth.capital.0249
Rajkot, Gujarat
5+ Years of experience
SEBI Registration INA000020040
Trade Ideas
942
Opinions
868
Followers
110k
Expertise
Quantitative
Growth
Technical
Index Strategies
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
Posts
shared an insight ⚡️ 5 hours ago
Lenskart Q1FY27: Growth at premium valuation z`
LENSKART
registered a 43.3% YoY growth in consolidated revenue for Q1 FY27, with consolidated EBITDA margins expanding to 21.7% from 17.7%. Growth was predominantly volume-driven, with domestic eyewear units climbing 22.8% and eye tests jumping 42.7%, expanding the overall customer pipeline.
Strong Domestic Presence & Low Cannibalisation: India revenue rose 30.7% YoY to ₹1,531 crore, anchored by an 18.3% Same-Store Sales Growth (SSSG). Net store additions reached 116 (mostly in Tier 2/3 markets). Same-pin-code sales growth (SPSG) outpaced SSSG at 24.3%, signaling that network density is expanding without cannibalising existing stores.
International Business Turnaround: International revenue grew 38% YoY to ₹1,203 crore, driven by high-margin seasonal products (sunglasses) and supply-chain integration with Owndays and Meller. EBITDA margin for the segment expanded significantly to 21.9% from 16.9%, achieved with minimal network additions.
Operating Leverage & Smart Eyewear Push: Consolidated product margin climbed to 70.3%, buoyed by lower marketing intensity and localized manufacturing at the Hyderabad plant. The brand also introduced "B by Lenskart"—a ₹22,000 smart eyewear product with audio, camera, and AI capabilities—generating over 80,000 early-access sign-ups to extend its ecosystem.
Improving Financial Health vs. High Valuations: Capital efficiency strengthened, as operating cash flow reached ₹297 crore (exceeding ₹207 crore capex) and Return on Capital Employed (ROCE) rose to 23.2%. However, with valuations at 33x FY28E EV/EBITDA and 7.2x EV/Sales, upside remains capped, leaving little margin for execution slip-ups. shared an insight ⚡️ 15th Aug
Apollo Hospitals Q1FY27: Broad-Based Growth & Strategic Expansion
APOLLOHOSP
registered a 21% year-over-year increase in consolidated revenue to ₹7,044 crore for Q1FY27. Net profit surged 34% YoY to ₹581 crore, while EBITDA rose 28% to ₹1,092 crore with margins expanding to 15.5%.
Robust Core Healthcare Growth: The primary hospital business grew 22% YoY to ₹3,567 crore, buoyed by a 13% rise in inpatient volume and 70% occupancy. Established facilities delivered a solid 25.9% EBITDA margin, offsetting temporary operational losses from new hospital facilities.
Narrowing Digital & Insurance Losses: Apollo HealthCo revenue jumped 20% to ₹2,977 crore, with EBITDA climbing 83% to ₹171 crore. Apollo 24/7 reduced its quarterly cash losses dramatically from ₹49 crore to ₹10 crore (aiming for Q2 break-even), while the insurance arm targets break-even by Q3FY27.
Diagnostic & Wellness Momentum: Apollo Health and Lifestyle Ltd (AHLL) posted a 15% revenue gain to ₹500 crore and narrowed net losses to ₹1 crore. Diagnostic revenues expanded 31%, heavily supported by a ~38% YoY surge in wellness offerings.
Aggressive Long-Term Capacity Expansion: Management projects ~20% hospital revenue growth for FY27. Operations expanded with a 180-bed Sarjapur facility, a Gurugram launch slated for Q3FY27, and plans to scale total bed capacity to ~14,100 by FY31.
Valuation & Regulatory Considerations: Despite strong operational visibility, potential regulatory risks surrounding price caps on private healthcare could weigh on valuations. Given the stock's ~25% year-to-date rally (trading at ~24x FY28e EV/EBITDA), analysts recommend booking partial profits with an Equal-weight stance. shared an insight ⚡️ 15th Aug
Tata Motors Q1FY27: JLR Headwinds Mask Domestic PV Growth
Jaguar Land Rover's near-term revenue and profitability were hampered by component supply chain issues, including a chassis-supplier fire, logistics delays linked to Middle East conflict, and planned model changeovers like the incoming Jaguar Type 01.
Record Domestic PV Performance:
TMPV
’ domestic passenger vehicle (PV) business outpaced industry growth with a 46% year-on-year surge in wholesales, elevating its market share to 14.3% and solidifying its position as India's second-largest PV manufacturer.
Powertrain Transition Acceleration: Clean mobility adoption picked up significantly, with EV and CNG vehicles reaching 46% of domestic volume and EV monthly production scaling past 15,000 units to maintain a market leadership share above 40%.
Commodity Headwinds on Margins: Domestic PV EBITDA margins expanded slightly to 4.3% supported by PLI accruals, but rising raw material costs imposed a 6% drag that is expected to keep near-term operating margins largely flat.
Future Expansion Levers: The company is expanding production capacity to resolve backlogs for popular models like the ***** while simultaneously aiming to double export volumes across newly opened international markets.
Muted Valuation Upside: Analysts maintain an Equal-weight outlook as macro risks and limited near-term visibility surrounding JLR offset domestic tailwinds, offering minimal safety margin for investors.FAQ's
What are the top stock recommendations by TrueNorth Capital?
TrueNorth Capital regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include LENSKART, APOLLOHOSP and TMPV. Explore TrueNorth Capital's complete list of posts and trade views on their StockGro profile.
How can I follow TrueNorth Capital's latest investment insights?
You can follow TrueNorth Capital's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is TrueNorth Capital's investment strategy?
TrueNorth Capital follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has TrueNorth Capital been a SEBI-registered Research Analyst (RA)?
TrueNorth Capital has been a SEBI-registered Research Analyst and have 5+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see TrueNorth Capital's past performance and stock picks?
You can check TrueNorth Capital's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact TrueNorth Capital for stock market advice?
For stock market guidance from TrueNorth Capital, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is TrueNorth Capital's track record in predicting market movements?
TrueNorth Capital has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for TrueNorth Capital?
TrueNorth Capital is a SEBI-registered Research Analyst with the SEBI Registration INA000020040. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
Be Financially Free with StockGro